Mr. David Light will be presenting his speech at #PharmaUCG
David Light, Founder and CEO of Valisure, is a biotech entrepreneur and scientist with over 10 years of broad experience in the field. A graduate of Yale University, David studied molecular biology and has worked in a variety of scientific and business roles at start-ups like Synthetic Genomics, Ion Torrent, and Valisure. At Ion Torrent, David developed key technologies that directly led to the semiconductor DNA sequencing company’s $725M acquisition and ran its flagship technology programs through development and global commercialization. David helped found, fund, and invent the core technology at Valisure. David is named inventor on numerous patents, published in journals including Nature and the cover of Electrophoresis, has been invited to submit testimony at congressional hearings as well as speak at the U.S. Capitol Building on the introduction of critical bills regarding medication safety and quality.
WELCOME TO DIGITAL PHARMACEUTICAL 2023
The UCG OCM would like to invite Pharmacists, experts, professors, students, practitioners, medical specialists, clinical scientists, technologists, and other healthcare professionals to the 12th Digital Pharmaceutical Innovations Exhibition & Congress on April 4-6, 2023 in Berlin, Germany. Our main aim is to bring leading researchers, scientists, and research scholars researchers to exchange, discuss, and share their experiences and research results about all aspects of Digital Pharmaceutical. This Conference aims to provide participants working in Digital Pharmaceuticals medicine with a venue in maintaining cutting-edge knowledge and skills in their fields including Pharmacology, Digital Pharmaceutical Sciences, Digital Pharmaceutical Biotechnology, Smart Drug Delivery Systems, Digital Pharmaceutical Engineering, Pharmacognosy, Digital Pharma, Clinical Pharmacy, Digital Pharmaceutical Analysis, Digital Pharmaceutical Chemistry, Digital Pharmaceutical Formulations, Digital Pharmaceutical Regulatory Science and other disciplines.
We look forward to making the Conference not only a learning opportunity but also offer a destination where you can enjoy and unwind yourself before you start your work. The Pharma Conference revolves around the theme – “Discover the World of Pharmaceuticals & Pharma Industry.” By attending the Digital Pharma Conference, you will have the chance to grow both career-wise and relation-wise. Your presence will be much appreciated.
Our best regards,
Chris Howie | European Life Science Specialist, UCG OCM
Digital Pharmaceuticals UCGConferences Experts
Digital Pharmaceuticals is the process of turning a new chemical entity (NCE) or old medicine into a medication to be used by patients safely. It is derived from the Greek word “pharmakeutikos” and called as the study of dosage form design. It is used in the diagnosis, treatment, and prevention of various diseases for restoring and modifying organic functions. Pharmaceutics is the formulation of the pure drug into a dosage form. The Digtial pharmaceutical company/industry discovers, develops, produces, and market those pharmaceutical drugs to be used as medication by the patients, to cure, immunize, relieve the symptoms. The fundamental of the Digital Pharmaceutical Company/ Industry is to control or eliminate diseases around the world.
Physicians of digital pharmaceuticals work in the digital pharmaceutical industry, medical schools/universities, other authorities, and research organizations. Digital pharmaceuticals, medicine, and drug are words used interchangeably. Such products must be safe, good quality, effective, and are prescribed by the specialist. Pharmaceutics branches include Digital Pharmaceutical Formulation, Digital Pharmaceutical Manufacturing, Dispensing Pharmacy, and Pharmaceutical Technology. Before marketing, pharmaceutical products can take many years to process through R&D phases. One of the lengthy part of Research and development includes getting approval from the FDA (Food and Drug Administration).
Digital Pharmaceuticals Conferences, Digital Pharmaceuticals Meetings, Digital Pharmaceuticals Congress, Digital Pharmaceuticals Workshop, Digital Pharmaceuticals Symposiums, Digital Pharmaceuticals Seminars, Pharmaceuticals Expo, Digital Pharmaceuticals Exhibitions, Digital Medical Conferences, Digital Medical Meetings, Digital Medical Congress, Digital Medical Workshop, Digital Medical Symposiums, Digital Medical Seminars, Digital Medical Expo, Digital Clinical Conference, Digital Pharmacy Conference, Biopharma Conferences, Digital Pharma Conference, Medical Exhibitions
What is the difference between CPD and CME Certifications?
CPD Certifications (Continuing Professional Development) is the process of lifelong learning where physicians acquire—through formal and informal education and their practice—the skills, knowledge, and attitude that they need to maintain the ability to practice and the competence to provide effective patient care. It is not only about medical knowledge.)
CME Certifications (Continued Medical Education) is mostly focused on medical knowledge and the physician’s medical expert role and consists of educational activities that serve to maintain, develop, or increase the knowledge, skills and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession.
Abstract submission deadline is December 31st, 2022
Conference Key Sessions
Track 1: Digital Pharmaceuticals
Track 2: Digital Industrial Pharmacy
Track 3: Digital Pharmacology & Toxicology
Track 4: Digital Pharmacogenomics & Pharmacogenetics
Track 5: Digital COVID-19 Drug Development
Track 6: Digital Pharmaceutical Biotechnology
Track 7: Drug Designing & Technology
Track 8: Vaccine
Track 9: COVID-19 Impact on World-Wide Pharma Sector
Track 10: Clinical and Hospital Pharmacy
Track 11: Digital Pharmaceutical Engineering
Track 12: Digital Pharmaceutical Business and Market
Track 13: Digital Pharmaceutical Quality Assurance
Track 14: Digital Pharmacognosy
Track 15: Digital Pharma
Track 16: Pharmacy Development Services
Track 17: Digital Pharmaceutical Microbiology
Track 18: Computer Applications in Pharmacy
Track 19: Drug Regulations
Track 20: Pharmaceutics
Track 21: Novel Drug Delivery Systems
Track 22: Cosmeceuticals
Track 23: Digital Pharmaceutical Nanotechnology
Track 24: Biosimilars
Track 25: Digital Biopharmaceuticals
Track 26: Digital Pharma Packaging
Email us for the conference program here: info@utilitarianconferences.com
Submit Abstract
All registered abstracts will be published on the website.
To Publish the full paper, case study, refer to our supporting journal; Global Research Journal of Pharmaceutical and Drug Discovery [GRJPDD]
Digital Object Identifier by Crossref, Indexed by Google Scholar, Scopus
ISSN National Centre for the UK
Unified Citation Journals is a platform for the latest discoveries in Technology, Science, engineering, medicine, medical clinical, and advancing discoveries and health. We at Unified Citation Journals ensure the advancement of healthcare and improve performance for the benefit of humanity.
Unified Citation Journals empowers and publish scientific research work. We will be including special issues and symposia papers in related journals from all over the world. Apart from publishing, we also promote upcoming books covering different fields of science, medicine, engineering, technology, etc. Unified Citation Journals help Authors, Publishers, and Distributors, in growing their business multifold.
CALL FOR ABSTRACTS is currently open!
Call for Abstracts is now open for the 12th Digital Pharmaceutical Innovations Exhibition & Congress during April 4-6, 2023 in Berlin, Germany with the motto “Discover the World of Digital Pharmaceuticals & Pharma Industry”
The presenting speaker/author must register and pay the registration fee (please note that registration is required in order to be included in the final program, to have the abstract published in the online “Book/proceedings” of Digital Pharmaceuticals 2023, and to be invited to submit an abstract for publication in the official Proceedings.
To submit your abstract/research paper for an oral or poster or young research presenter contribution to Digital Pharmaceuticals 2023 please fill in your details in the abstract submission form. Once you submit your details, you can upload your abstract (format allowed: .doc / .docx / .pdf). The author’s account is must needed for communication purposes. Abstracts can be submitted by email. Speakers/Presenters can submit a maximum of three abstracts. All abstracts must be submitted in English. Please do not submit too many copies of the same abstract. All abstracts will be forwarded to the Scientific and Program Committee member for the review process. Once accepted, you will receive a confirmation email from our side.
Tweets by PharmaUCG
|
